
Fibroadenoma Market Research Report Information by Type (Simple Fibroadenoma and Complex Fibroadenoma), by Diagnosis & Treatment (Diagnosis [Ultrasound Scan, Mammography, and Biopsy] and Treatment [Cryoablation, High Intensity Focused Ultrasound (HIFU), L
Description
Fibroadenoma Market Research Report Information by Type (Simple Fibroadenoma and Complex Fibroadenoma), by Diagnosis & Treatment (Diagnosis [Ultrasound Scan, Mammography, and Biopsy] and Treatment [Cryoablation, High Intensity Focused Ultrasound (HIFU), Lumpectomy, and Drugs {Dydrogesterone, Medroxyprogesterone, Selective Estrogen Receptor Modulators, and Others}], by End User (Hospital and Clinics, Diagnostic Centers, and Others) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) – Industry Forecast till 2032
Market synopsis
The market for fibroadenoma was estimated to be worth USD 0.71 billion in 2023. According to projections, the Fibroadenoma Market market will expand at a compound annual growth rate (CAGR) of 6.36% from USD 0.77 billion in 2024 to USD 1.34 billion by 2032.
The main factors propelling the growth of the fibroedema market are rising occurrences of fibroadenoma among women and increased awareness of the condition through public education programs.
One of the key factors propelling the fibroadenoma market is the greater public awareness of the condition brought about by education initiatives. Campaigns for public education are essential in educating women about the symptoms and indicators of fibroadenoma. This increased awareness motivates women to have frequent breast exams and screenings and fosters proactive health-seeking behavior. Timely intervention and adequate care of fibroadenomas depend on early identification. Additionally, public education initiatives serve to debunk false beliefs and preconceptions around breast lumps, hence reducing unwarranted worry and anxiety related to such findings.
Moreover, one of the main factors propelling the fibroadenoma market's expansion is the advancement of better diagnostic methods. For prompt and effective medical intervention, it is essential to accurately identify fibroadenomas, and improvements in diagnostic instruments have greatly increased the sensitivity of detection. Improved diagnostic methods allow medical practitioners to identify fibroadenomas early on. Improving patient outcomes, lowering the risk of complications, and implementing prompt and focused treatment options all depend on early detection. The diagnosis method for fibroadenomas has been completely transformed by the development and application of non-invasive imaging technologies including magnetic resonance imaging (MRI) and ultrasound.
Insights on market segments
The Fibroadenoma Market is divided into simple and complex fibroadenomas based on kind.
The fibroadenoma market is divided into two segments based on diagnosis and treatment.
The fibroadenoma market is divided into ambulatory surgery centers, hospitals & clinics, and other end users.
Regional Perspectives
Because of its modern medical infrastructure, insurance coverage, payment regulations, and advanced diagnostic procedures, North America held the greatest market share in 2022—more than 38.49%. In addition, compared to people in other countries, North Americans often have better access to healthcare and are more conscious of health issues. This results in increased screenings and fibroadenoma diagnosis, even in cases where there are no symptoms.
With a heavy emphasis on minimally invasive methods such as cryoablation and vacuum-assisted excision for fibroadenomas, the market for fibroadenomas in Europe is expected to increase significantly during the forecast year, 2024–2022. Due to their ability to carry out these operations, the region's hospitals and clinics draw patients looking for less intrusive alternatives.
Due to the regular introduction of breast diagnostic and treatment equipment through expansion, the Asia-Pacific fibroadenoma market is expected to develop at the quickest rate over the forecast period. IceCure Medical Ltd. declared in May 2023 that Kovai Medical Center and Hospital (KMCH) in India has installed and inaugurated ProSense.
Principal Players
Pfizer, Inc. (US), GE Healthcare (US), Koninklijke Philips N.V. (Germany), Shimadzu Corporation (Japan), Siemens Healthineers (Germany), Dilon Technologies (US), IceCure Medical (Israel), Alpinion Medical Systems (South Korea), and Fujifilm Holdings Corporation (Japan) are some of the major players in the fibroadenoma market.
Table of Contents
136 Pages
- 1 Executive Summary
- 2 Market Introduction
- 2.1 Definition
- 2.2 Scope Of The Study
- 2.3 Research Objective
- 2.4 Market Structure
- 3 Research Methodology
- 3.1 Overview
- 3.2 Data Flow
- 3.2.1 Data Mining Process
- 3.3 Purchased Database:
- 3.4 Secondary Sources:
- 3.4.1 Secondary Research Data Flow:
- 3.5 Primary Research:
- 3.5.1 Primary Research Data Flow:
- 3.5.2 Primary Research: Number Of Interviews Conducted
- 3.5.3 Primary Research: Regional Coverage
- 3.6 Approaches For Market Size Estimation:
- 3.6.1 Revenue Analysis Approach
- 3.7 Data Forecasting
- 3.7.1 Data Forecasting Technique
- 3.8 Data Modeling
- 3.8.1 Microeconomic Factor Analysis:
- 3.8.2 Data Modeling:
- 3.9 Teams And Analyst Contribution
- 4 Market Dynamics
- 4.1 Introduction
- 4.2 Drivers
- 4.2.1 Increased Awareness About Fibroadenoma Through Public Education Campaigns
- 4.2.2 Development Of Improved Diagnostic Techniques To Accurately Identify Fibroadenoma
- 4.2.3 Increasing Prevalence Of Fibroadenoma Among Women
- 4.3 Restraints
- 4.3.1 High Cost Of Treatment Of Fibroadenoma
- 4.4 Opportunity
- 4.4.1 Research Into New Treatment Options For Fibroadenoma, Such As Minimally Invasive Surgical Procedures Or Medications
- 4.4.2 Growing Adoption Of Minimally Invasive Surgical Procedures For The Treatment Of Fibroadenoma
- 4.5 Challenges
- 4.5.1 Non-life Threatening Nature Of Fibroadenomas
- 4.6 Impact Analysis Of Covid-
- 4.6.1 Impact 0n Overall Fibroadenoma Industry
- 4.6.1.1 Economic Impact
- 4.6.2 Impact On Global Fibroadenoma Market
- 4.6.3 Impact On The Supply Chain Of Fibroadenoma
- 4.6.4 Impact On Market Demand Of Fibroadenoma
- 4.6.4.1 Impact Due To Restrictions/Lockdown
- 4.6.4.2 Consumer Sentiments
- 4.6.5 Impact On Pricing Of Fibroadenoma
- 5 Market Factor Analysis
- 5.1 Value Chain Analysis
- 5.1.1 Raw Materials
- 5.1.2 Manufacturing / Production/ Processing
- 5.1.3 Distribution Channel
- 5.1.4 End-user
- 5.2 Porter’s Five Forces Model
- 5.2.1 Bargaining Power Of Suppliers
- 5.2.2 Bargaining Power Of Buyers
- 5.2.3 Threat Of New Entrants
- 5.2.4 Threat Of Substitutes
- 5.2.5 Intensity Of Rivalry
- 6 Global Fibroadenoma Market, By Type
- 6.1 Introduction
- 6.2 Simple Fibroadenoma
- 6.3 Complex Fibroadenoma
- 7 Global Fibroadenoma Market, By Diagnosis & Treatment
- 7.1 Introduction
- 7.2 Diagnosis
- 7.2.1 Ultrasound Scan
- 7.2.2 Mammography
- 7.2.3 Biopsy
- 7.3 Treatment
- 7.3.1 Cryoblation
- 7.3.2 High Intensity Focused Ultrasound (Hifu)
- 7.3.3 Lumpectomy
- 7.3.4 Drugs
- 7.3.4.1 Dydrogesterone
- 7.3.4.2 Medroxyprogesterone
- 7.3.4.3 Selective Estrogen Receptor Modulators
- 7.3.4.4 Others
- 8 Global Fibroadenoma Market, By End-user
- 8.1 Introduction
- 8.2 Hospital And Clinics
- 8.3 Diagnostic Centers
- 8.4 Others
- 9 Global Fibroadenoma Market, By Region
- 9.1 Overview
- 9.2 North America
- 9.2.1 Us
- 9.2.2 Canada
- 9.2.3 Mexico
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 France
- 9.3.3 Uk
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest Of Europe
- 9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 India
- 9.4.3 Japan
- 9.4.4 South Korea
- 9.4.5 Australia
- 9.4.6 Rest Of Asia Pacific
- 9.5 Rest Of The World
- 9.5.1 South America
- 9.5.2 Middle East & Africa
- 10 Competitive Landscape
- 10.1 Introduction
- 10.2 Competition Dashboard
- 10.3 Market Share Analysis, 2
- 10.4 Public Players Stock Summary
- 10.5 Key Developments & Growth Strategies
- 10.5.1 Product Launch
- 10.5.2 Partnership
- 10.5.3 Expansion
- 11 Company Profiles
- 11.1 Ge Healthcare
- 11.1.1 Company Overview
- 11.1.2 Financial Overview
- 11.1.3 Products Offered
- 11.1.4 Key Developments
- 11.1.5 Swot Analysis
- 11.1.6 Key Strategy
- 11.2 Koninklijke Philips N.V.
- 11.2.1 Company Overview
- 11.2.2 Financial Overview
- 11.2.3 Products Offered
- 11.2.4 Key Developments
- 11.2.5 Swot Analysis
- 11.2.6 Key Strategy
- 11.3 Shimadzu Corporation
- 11.3.1 Company Overview
- 11.3.2 Financial Overview
- 11.3.3 Products Offered
- 11.3.4 Key Developments
- 11.3.5 Swot Analysis
- 11.3.6 Key Strategy
- 11.4 Siemens Healthineers
- 11.4.1 Company Overview
- 11.4.2 Financial Overview
- 11.4.3 Products Offered
- 11.4.4 Key Developments
- 11.4.5 Swot Analysis
- 11.4.6 Key Strategy
- 11.5 Canon Medical Systems Corporation
- 11.5.1 Company Overview
- 11.5.2 Financial Overview
- 11.5.3 Products Offered
- 11.5.4 Swot Analysis
- 11.5.5 Key Developments
- 11.5.6 Key Strategy
- 11.6 Dilon Technologies
- 11.6.1 Company Overview
- 11.6.2 Products Offered
- 11.6.3 Swot Analysis
- 11.6.4 Key Developments
- 11.6.5 Key Strategy
- 11.7 Pfizer, Inc
- 11.7.1 Company Overview
- 11.7.2 Financial Overview
- 11.7.3 Products Offered
- 11.7.4 Key Developments
- 11.7.5 Swot Analysis
- 11.7.6 Key Strategy
- 11.8 Icecure Medical
- 11.8.1 Company Overview
- 11.8.2 Financial Overview
- 11.8.3 Products Offered
- 11.8.4 Key Developments
- 11.8.5 Swot Analysis
- 11.8.6 Key Strategy
- 11.9 Alpinion Medical Systems
- 11.9.1 Company Overview
- 11.9.2 Products Offered
- 11.9.3 Key Developments
- 11.9.4 Swot Analysis
- 11.9.5 Key Strategy
- 11.10 Fujifilm Holdings Corporation
- 11.10.1 Company Overview
- 11.10.2 Products Offered
- 11.10.3 Key Developments
- 11.10.4 Swot Analysis
- 11.10.5 Key Strategy
- 12 Appendix
- 12.1 References
- 12.2 Related Reports
- List Of Tables
- Table 1 Qfd Modeling For Market Share Assessment
- Table 2 Global Fibroadenoma Market, By Type, 2019-2032 (Usd Mllion)
- Table 3 Global Fibroadenoma Market Estimates & Forecast, By Simple Fibroadenoma, 2019-2032 (Usd Mllion)
- Table 4 Global Fibroadenoma Market Estimates & Forecast, By Complex Fibroadenoma, 2019-2032 (Usd Mllion)
- Table 5 Global Fibroadenoma Market, By Diagnosis & Treatment, 2019-2032 (Usd Mllion)
- Table 6 Global Fibroadenoma Market Estimates & Forecast, By Diagnosis, 2019-2032 (Usd Mllion)
- Table 7 Global Fibroadenoma Market Estimates & Forecast, By Treatment, 2019-2032 (Usd Mllion)
- Table 8 Global Fibroadenoma Market, By End-user, 2019-2032 (Usd Mllion)
- Table 9 Global Fibroadenoma Market Estimates & Forecast, By Hospital And Clinics, 2019-2032 (Usd Mllion)
- Table 10 Global Fibroadenoma Market Estimates & Forecast, By Diagnostic Centers, 2019-2032 (Usd Mllion)
- Table 11 Global Fibroadenoma Market Estimates & Forecast, By Others, 2019-2032 (Usd Mllion)
- Table 12 Global Fibroadenoma Market, By Region, 2019-2032 (Usd Mllion)
- Table 13 North America Fibroadenoma Market, By Country, 2019-2032 (Usd Mllion)
- Table 14 North America Fibroadenoma Market, By Type, 2019-2032 (Usd Mllion)
- Table 15 North America Fibroadenoma Market, By Diagnosis & Treatment, 2019-2032 (Usd Mllion)
- Table 16 North America Fibroadenoma Market, By End-user, 2019-2032 (Usd Mllion)
- Table 17 Us Fibroadenoma Market, By Type, 2019-2032 (Usd Mllion)
- Table 18 Us Fibroadenoma Market, By Diagnosis & Treatment, 2019-2032 (Usd Mllion)
- Table 19 Us Fibroadenoma Market, By End-user, 2019-2032 (Usd Mllion)
- Table 20 Canada Fibroadenoma Market, By Type, 2019-2032 (Usd Mllion)
- Table 21 Canada Fibroadenoma Market, By Diagnosis & Treatment, 2019-2032 (Usd Mllion)
- Table 22 Canada Fibroadenoma Market, By End-user, 2019-2032 (Usd Mllion)
- Table 23 Mexico Fibroadenoma Market, By Type, 2019-2032 (Usd Mllion)
- Table 24 Mexico Fibroadenoma Market, By Diagnosis & Treatment, 2019-2032 (Usd Mllion)
- Table 25 Mexico Fibroadenoma Market, By End-user, 2019-2032 (Usd Mllion)
- Table 26 Europe Fibroadenoma Market, By Country, 2019-2032 (Usd Mllion)
- Table 27 Europe Fibroadenoma Market, By Type, 2019-2032 (Usd Mllion)
- Table 28 Europe Fibroadenoma Market, By Diagnosis & Treatment, 2019-2032 (Usd Mllion)
- Table 29 Europe Fibroadenoma Market, By End-user, 2019-2032 (Usd Mllion)
- Table 30 Germany Fibroadenoma Market, By Type, 2019-2032 (Usd Mllion)
- Table 31 Germany Fibroadenoma Market, By Diagnosis & Treatment, 2019-2032 (Usd Mllion)
- Table 32 Germany Fibroadenoma Market, By End-user, 2019-2032 (Usd Mllion)
- Table 33 France Fibroadenoma Market, By Type, 2019-2032 (Usd Mllion)
- Table 34 France Fibroadenoma Market, By Diagnosis & Treatment, 2019-2032 (Usd Mllion)
- Table 35 France Fibroadenoma Market, By End-user, 2019-2032 (Usd Mllion)
- Table 36 Uk Fibroadenoma Market, By Type, 2019-2032 (Usd Mllion)
- Table 37 Uk Fibroadenoma Market, By Diagnosis & Treatment, 2019-2032 (Usd Mllion)
- Table 38 Uk Fibroadenoma Market, By End-user, 2019-2032 (Usd Mllion)
- Table 39 Spain Fibroadenoma Market, By Type, 2019-2032 (Usd Mllion)
- Table 40 Spain Fibroadenoma Market, By Diagnosis & Treatment, 2019-2032 (Usd Mllion)
- Table 41 Spain Fibroadenoma Market, By End-user, 2019-2032 (Usd Mllion)
- Table 42 Italy Fibroadenoma Market, By Type, 2019-2032 (Usd Mllion)
- Table 43 Italy Fibroadenoma Market, By Diagnosis & Treatment, 2019-2032 (Usd Mllion)
- Table 44 Italy Fibroadenoma Market, By End-user, 2019-2032 (Usd Mllion)
- Table 45 Rest Of Europe Fibroadenoma Market, By Type, 2019-2032 (Usd Mllion)
- Table 46 Rest Of Europe Fibroadenoma Market, By Diagnosis & Treatment, 2019-2032 (Usd Mllion)
- Table 47 Rest Of Europe Fibroadenoma Market, By End-user, 2019-2032 (Usd Mllion)
- Table 48 Asia Pacific Fibroadenoma Market, By Country, 2019-2032 (Usd Mllion)
- Table 49 Asia Pacific Fibroadenoma Market, By Type, 2019-2032 (Usd Mllion)
- Table 50 Asia Pacific Fibroadenoma Market, By Diagnosis & Treatment, 2019-2032 (Usd Mllion)
- Table 51 Asia Pacific Fibroadenoma Market, By End-user, 2019-2032 (Usd Mllion)
- Table 52 China Fibroadenoma Market, By Type, 2019-2032 (Usd Mllion)
- Table 53 China Fibroadenoma Market, By Diagnosis & Treatment, 2019-2032 (Usd Mllion)
- Table 54 China Fibroadenoma Market, By End-user, 2019-2032 (Usd Mllion)
- Table 55 India Fibroadenoma Market, By Type, 2019-2032 (Usd Mllion)
- Table 56 India Fibroadenoma Market, By Diagnosis & Treatment, 2019-2032 (Usd Mllion)
- Table 57 India Fibroadenoma Market, By End-user, 2019-2032 (Usd Mllion)
- Table 58 Japan Fibroadenoma Market, By Type, 2019-2032 (Usd Mllion)
- Table 59 Japan Fibroadenoma Market, By Diagnosis & Treatment, 2019-2032 (Usd Mllion)
- Table 60 Japan Fibroadenoma Market, By End-user, 2019-2032 (Usd Mllion)
- Table 61 South Korea Fibroadenoma Market, By Type, 2019-2032 (Usd Mllion)
- Table 62 South Korea Fibroadenoma Market, By Diagnosis & Treatment, 2019-2032 (Usd Mllion)
- Table 63 South Korea Fibroadenoma Market, By End-user, 2019-2032 (Usd Mllion)
- Table 64 Australia Fibroadenoma Market, By Type, 2019-2032 (Usd Mllion)
- Table 65 Australia Fibroadenoma Market, By Diagnosis & Treatment, 2019-2032 (Usd Mllion)
- Table 66 Australia Fibroadenoma Market, By End-user, 2019-2032 (Usd Mllion)
- Table 67 Rest Of Asia Pacific Fibroadenoma Market, By Type, 2019-2032 (Usd Mllion)
- Table 68 Rest Of Asia Pacific Fibroadenoma Market, By Diagnosis & Treatment, 2019-2032 (Usd Mllion)
- Table 69 Rest Of Asia Pacific Fibroadenoma Market, By End-user, 2019-2032 (Usd Mllion)
- Table 70 Rest Of The World Fibroadenoma Market, By Country, 2019-2032 (Usd Mllion)
- Table 71 Rest Of The World Fibroadenoma Market, By Type, 2019-2032 (Usd Mllion)
- Table 72 Rest Of The World Fibroadenoma Market, By Diagnosis & Treatment, 2019-2032 (Usd Mllion)
- Table 73 Rest Of The World Fibroadenoma Market, By End-user, 2019-2032 (Usd Mllion)
- Table 74 South America Fibroadenoma Market, By Type, 2019-2032 (Usd Mllion)
- Table 75 South America Fibroadenoma Market, By Diagnosis & Treatment, 2019-2032 (Usd Mllion)
- Table 76 South America Fibroadenoma Market, By End-user, 2019-2032 (Usd Mllion)
- Table 77 Middle East & Africa Fibroadenoma Market, By Type, 2019-2032 (Usd Mllion)
- Table 78 Middle East & Africa Fibroadenoma Market, By Diagnosis & Treatment, 2019-2032 (Usd Mllion)
- Table 79 Middle East & Africa Fibroadenoma Market, By End-user, 2019-2032 (Usd Mllion)
- Table 80 Public Players Stock Summary
- Table 81 Product Launch
- Table 82 Partnership
- Table 83 Expansion
- Table 84 Ge Healthcare: Products Offered
- Table 85 Koninklijke Philips N.V.: Products Offered
- Table 86 Shimadzu Corporation: Products Offered
- Table 87 Shimadzu Corporation: Key Developments
- Table 88 Siemens Healthineers: Products Offered
- Table 89 Siemens Healthineers: Key Developments
- Table 90 Canon Medical Systems Corporation: Products Offered
- Table 91 Canon Medical Systems Corporation: Key Developments
- Table 92 Dilon Technologies: Products Offered
- Table 93 Dilon Technologies: Key Developments
- Table 94 Pfizer, Inc: Products Offered
- Table 95 Icecure Medical: Products Offered
- Table 96 Alpinion Medical Systems: Products Offered
- Table 97 Fujifilm Holdings Corporation: Products Offered
- List Of Figures
- Figure 1 Global Fibroadenoma Market: Structure
- Figure 2 Global Fibroadenoma Market: Market Growth Factor Analysis (2022-2032)
- Figure 3 Driver Impact Analysis (2024-2032)
- Figure 4 Porter’s Five Forces Model: Global Fibroadenoma Market
- Figure 5 Global Fibroadenoma Market, By Type, Segment Attractiveness Analysis
- Figure 6 Global Fibroadenoma Market, By Type, 2022 (% Share)
- Figure 7 Global Fibroadenoma Market, By Diagnosis & Treatment, Segment Attractiveness Analysis
- Figure 8 Global Fibroadenoma Market, By Diagnosis & Treatment, 2022 (% Share)
- Figure 9 Global Fibroadenoma Market, By End-user, Segment Attractiveness Analysis
- Figure 10 Global Fibroadenoma Market, By End-user, 2022 (% Share)
- Figure 11 Global Fibroadenoma Market, By Region, 2022 (% Share)
- Figure 12 North America Market: Comparative Analysis
- Figure 13 North America Market: Swot Analysis
- Figure 14 North America Fibroadenoma Market, By Country, 2022 (% Share)
- Figure 15 Europe Market: Comparative Analysis
- Figure 16 Europe Fibroadenoma Market, By Country, 2022 (% Share)
- Figure 17 Europe Market: Swot Analysis
- Figure 18 Asia Pacific Market: Comparative Analysis
- Figure 19 Asia Pacific Fibroadenoma Market, By Country, 2022 (% Share)
- Figure 20 Asia Pacific Market: Swot Analysis
- Figure 21 Rest Of The World Market: Comparative Analysis
- Figure 22 Rest Of The World Fibroadenoma Market, By Country, 2022 (% Share)
- Figure 23 Rest Of The World Market: Swot Analysis
- Figure 24 Competitor Dashboard: Global Fibroadenoma Market
- Figure 25 Global Fibroadenoma Market: Competitive Analysis, 2
- Figure 26 Ge Healthcare: Financial Overview Snapshot
- Figure 27 Ge Healthcare: Swot Analysis
- Figure 28 Koninklijke Philips N.V.: Swot Analysis
- Figure 29 Shimadzu Corporation: Swot Analysis
- Figure 30 Siemens Healthineers: Swot Analysis
- Figure 31 Canon Medical Systems Corporation: Swot Analysis
- Figure 32 Dilon Technologies: Swot Analysis
- Figure 33 Pfizer, Inc: Swot Analysis
- Figure 34 Icecure Medical: Swot Analysis
- Figure 35 Alpinion Medical Systems: Swot Analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.